Page 51 - Commercial Development News Today

/PRNewswire/ -- Exeest, the 24/7 global virtual entertainment marketplace for premium film and television content discovery and delivery, today announced John...

As the deal between Norwich City FC and their new shirt sponsor hangs in the balance amid outrage from fans over sexualised marketing by the Asian betting...

Who are they, where are they? On its website, BK8 explains: “BK8 is an online casino in Asia where you can get a whole lot of bang for your dough. It operates in Malaysia, Indonesia, Thailand, and Vietnam, among other countries.” But online gambling is illegal in Malaysia, Indonesia, Thailand and Vietnam, so the firm cannot be headquartered in those countries.  We asked Norwich City FC for contact details for BK8, and for details about BK8, without reply. We submitted questions via the Con...

As the deal between Norwich City FC and their new shirt sponsor hangs in the balance amid outrage from fans over sexualised marketing by the Asian betting...

The reserve price is fixed at ₹25 crore for a 45-year lease period.

Pursuant to the Swedish Act on Public Procurement, Swedavia has signed an agreement with ExpressCare to set up a test center at Göteborg Landvetter Airport. ExpressCare performs PCR and antibody tests...

The Rail Land Development Authority (RLDA) has invited e-bids for leasing 10,080 square metres (sqm) vacant land parcel for commercial development at Amravati i

Bhavnagar (Gujarat) [India], June 1 (ANI): Rail Land Development Authority (RLDA) on Tuesday invited online bids for leasing vacant land parcel apanning across 4969 square meters, for residential cum commercial development, informed RLDA.

Jun 01 2021 Opposition to a second Japanese patent, applied for in relation to the use of CRISPR methods in cellular studies, has been rejected by the Japanese Patent Office (JPO), reports ERS Genomics, the Dublin-based company providing access to this technology. “The JPO actions reinforce the broad and fundamental nature of our CRISPR patent portfolio, both in Japan and worldwide.” Michael Arciero Japanese patent (JP6692856), filed by CRISPR/Cas9 intellectual property co-o...

Arguments filed in opposition to JP6692856 rejected JP2019-210828 represents third Japanese patent ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9